The positioning and dynamics of organelles in eukaryotic cells critically depend on membrane-cytoskeleton interactions. Motor proteins play an important role in the directed movement of organelle membranes along microtubules, but the basic mechanism by which membranes stably interact with the microtubule cytoskeleton is largely unknown. Here we report that p63, an integral membrane protein of the reticular subdomain of the rough endoplasmic reticulum (ER), binds microtubules in vivo and in vitro. Overexpression of p63 in cell culture led to a striking rearrangement of the ER and to concomitant bundling of microtubules along the altered ER. Mutational analysis of the cytoplasmic domain of p63 revealed two determinants responsible for these changes: an ER rearrangement determinant near the N-terminus and a central microtubule-binding region. The two determinants function independently of one another as indicated by deletion experiments. A peptide corresponding to the cytoplasmic tail of p63 promoted microtubule polymerization in vitro. p63 is the first identified integral membrane protein that can link a membrane organelle directly to microtubules. By doing so, it may contribute to the positioning of the ER along microtubules.
Introduction
Interactions between intracellular membranes and the microtubule cytoskeleton determine the structure and positioning of organelles and direct their dynamic movements (for reviews see Allan, 1995a; Cole and LippincottSchwartz, 1995; Richard and Kreis, 1995; Schroer and Gill, 1996; Vallee and Sheetz, 1996; Goodson et al., 1997) . Membranes can associate with microtubules either dynamically or in a stable fashion, depending on the properties of the linking molecules.
Dynamic interactions are required for membrane traffic and involve microtubule motors such as kinesin and dynein (Walker and Sheetz, 1993; Holzbaur and Vallee, 1994; Schrorer and Gill, 1996; Vallee and Sheetz, 1996; Presley et al., 1997; Schnapp, 1997; Hirokawa, 1998) . The transport of membranes along microtubules is powered by a 6168 © Oxford University Press complex of at least two proteins: a motor protein that binds to microtubules provides motility and a cargo protein that anchors the motor molecule to the membrane. Examples of such interactions are the plus-end motor protein kinesin and kinesin-related proteins which are thought to bind to membranes via the putative membrane receptor kinectin (Toyoshima et al., 1992; Burkhardt, 1996; Vallee and Sheetz, 1996; Hirokawa, 1998) and the minus-end motor protein cytoplasmic dynein that binds to membranes via the soluble protein complex dynactin (Echeverri et al., 1996; Burkhardt et al., 1997) , perhaps involving the ankyrin-spectrin network (Hirokawa, 1998) . In vitro studies suggest that motor proteins also play a role in the dynamics of organelles such as tubular network formation of the endoplasmic reticulum (ER; Dabora and Sheetz, 1988; Vale and Hotani, 1988; Allan, 1995b) . Tubule formation at the trans-Golgi (Cooper et al., 1990) may also depend on motor proteins.
In contrast, more stable interactions must be responsible for the positioning and structural maintenance of organelles including the ER (Terasaki et al., 1986; Lee and Chen, 1988) and the Golgi apparatus (Thyberg and Moskalewski, 1985; Cole et al., 1996) . Such interactions are assumed to utilize soluble non-motor microtubule-binding proteins. Cytoplasmic linker proteins (CLIPs) are a class of these proteins (Rickard and Kreis, 1996) , the most prominent member of which is CLIP-170 that links microtubules via a putative membrane anchor to endosomes (Scheel and Kreis, 1991; Pierre et al., 1992) . A different mechanism allowing the attachment and translocation of membranes independently of classical motor proteins has been found in an experimental assay using Xenopus egg extracts (Waterman-Storer et al., 1995) . In this in vitro system, ER membranes became attached to the growing plus ends of microtubules by membrane-microtubule tip attachment complexes by a mechanism insensitive to inhibitors of motility produced by conventional kinesins and dyneins. The molecular mechanism mediating this interaction is unknown.
Here we describe a novel type of membrane-microtubule interaction that is mediated directly by an integral membrane protein, p63. p63 is a 63 kDa non-glycosylated type II integral ER membrane protein with an extracytoplasmic domain of 474 amino acids and an N-terminal cytoplasmic domain of 106 amino acids (Schweizer et al., 1993a (Schweizer et al., ,b, 1994 (Schweizer et al., , 1995 . The protein is palmitoylated reversibly during mitosis and under conditions that interfere with intracellular protein transport (Mundy and Warren, 1992; Schweizer et al., 1993a; Mundy, 1995) . Moreover, it is up-regulated in the liver after cardiogenic shock resuscitation (Buchman et al., 1990; Schweizer et al., 1993b) , but the function of p63 is unknown. We report that the overexpression of p63 rearranges the ER and bundles microtubules along the altered ER membranes.
From in vivo and in vitro experiments, we conclude that p63 can bind directly to microtubules via its cytoplasmic domain and that the cytoplasmic domain is sufficient for this novel type of membrane-microtubule interaction.
Results
Overexpression of p63 rearranges the ER and microtubules By immunofluorescence confocal laser scanning microscopy (CLSM), endogenous p63 of non-transfected COS cells is localized in the cytoplasm in a punctate/reticular pattern that is typical for the ER ( Figure 1A) , with the notable exception that the protein is largely excluded from the nuclear membrane as has been observed previously (Schweizer et al., 1993a (Schweizer et al., , 1995 . If the cell borders were outlined by labeling the cell surface for the α-subunit of Na,K-ATPase, it was apparent that the ER classically extended to the periphery of the cell ( Figure 1B and C) .
Overexpression of p63 in cell culture can lead to a rearrangement of the ER network into an unusual tubular pattern (Schweizer et al., 1993b (Schweizer et al., , 1995 . Figure 1D shows this phenomenon by CLSM. The punctate/reticular pattern of p63 changed to characteristic p63-positive tubules surrounding the nucleus upon overexpression of wild-type p63. That this change indeed reflects redistribution of the ER and not just p63 was confirmed by immunofluorescence double-labeling experiments with antibodies against total ER, and against the ER marker proteins ERP72 and BAP31. These ER markers perfectly co-localized with the p63-positive reticular pattern in non-transfected cells as well as with the p63-positive tubules induced by transfecting the cells with wild-type p63 cDNA (not shown). Under overexpressing conditions, p63 was not mislocalized to either the cell surface (Schweizer et al., 1994) or the outer nuclear envelope, as shown by double-labeling for the nuclear pore complex protein p62 ( Figure 1H and I), and thus the induced changes in p63 localization concern the ER only.
To determine whether these changes in ER morphology involve the cytoskeleton, we stained the cells for actin, vimentin or tubulin. The patterns of actin and vimentin were unaffected by the overexpression of wild-type p63 (not shown), indicating that microfilaments and intermediate filaments were not affected by the rearrangement of the ER. To test whether microtubules were involved, COS cells overexpressing wild-type p63 were doublestained for p63 and tubulin and analyzed by CLSM. Unlike the microfilaments and intermediate filaments, the microtubules underwent a dramatic change upon overexpression of p63 ( Figure 1E ). They no longer radiated into the peripheral cytoplasm, appeared thickened and, most notably, aligned with the p63-positive tubular structures ( Figure 1F ). At least 40% of transfected COS cells consistently showed this parallel change of ER and microtubules. The same phenomenon could be observed in CHO cells stably transfected with wild-type p63 cDNA (not shown). These observations suggest that p63 may mediate an interaction of ER membranes with microtubules in vivo that either becomes apparent or is induced by overexpression of p63.
To test whether p63 can bind to microtubules in vitro, detergent cell extracts of COS cells overexpressing p63
were incubated with taxol-stabilized microtubules of pig brain, and co-sedimentation of p63 with microtubules was analyzed by SDS-PAGE and Western blotting (Figure 2A) . A considerable fraction of p63 (typically~40-60%) was indeed found in the pellet fraction and this sedimentation was dependent on the presence of microtubules. Because these experiments cannot discriminate between a direct and an indirect interaction of p63 with microtubules, we also performed experiments with monoclonal antibody (mAb) affinity-purified p63 instead of detergent extracts. Figure 2A shows that purified p63 isolated from transfected cells binds to microtubules to a similar extent as p63 from detergent extracts. Likewise, endogenous p63 purified from non-transfected cells was equally efficient in binding to microtubules in vitro. Although the affinity-purified p63 fraction used for the binding assay did not reveal any major contaminating bands on silver-stained SDS gels (not shown), our data at this point leave open the possibility that p63 binds to microtubules indirectly rather than directly (but see below).
Microtubule redistribution depends on p63's cytoplasmic domain
The bundling of microtubules along the ER in vivo suggested that the overexpression of p63 enhanced the interaction of the two components and did not just change the morphology of the ER. Together with the above observation that p63 can bind to microtubules in vitro, these findings pointed to an ER-microtubule linker function of p63. We therefore asked whether p63 carries a microtubulebinding determinant in its cytoplasmic domain. Such a determinant would have to be novel because the sequence of p63 does not reveal any of the microtubule-binding motifs known in microtubule-associated proteins. To test this assumption, we generated p63 mutants with deletions in different regions of the cytoplasmic domain and tested their effects by overexpressing them in COS cells. According to previous results (Schweizer et al., 1994) , amino acids 1-23 of the cytoplasmic tail of p63 are sufficient to induce the morphological changes of the ER. Are they also sufficient for microtubule binding? Deletion construct Δ24-101 induced an ER redistribution similar to wildtype p63 but the ER tubules appeared shorter, thinner and were more concentrated near the center of the cell as shown by CLSM ( Figure 3A ). The ER tubules accumulated close to the nucleus ( Figure 3D and E) and did not extend into the peripheral cytoplasm (compare Figure 3G -I). However, the microtubule pattern remained unchanged in cells overexpressing Δ24-101 ( Figure 3B ). The microtubules neither co-aligned with p63 tubules ( Figure 3C ) nor did they increase in thickness. Consistent with this, the mutant protein Δ24-101 was unable to bind to microtubules in the in vitro binding assay, irrespective of whether it originated from detergent extracts or affinity purification ( Figure 2B ). The observations that the ER can tubulate without altering the general microtubule appearance and that the Δ24-101 construct did not bind to microtubules in vitro show that the cytoplasmic domain of p63 is required for microtubule binding.
The cytoplasmic domain of p63 carries two functionally distinct determinants
The results with the Δ24-101 construct also suggest that the microtubule-binding determinant and the tubulation . After 48 h, the cells were fixed with paraformaldehyde, permeabilized with saponin, double-stained for p63 (A, D, G and J), tubulin (E), Na,K-ATPase (B and K) or the nuclear pore complex protein p62 (H), and analyzed by immunofluorescence confocal laser scanning microscopy (CLSM). Note that overexpression of p63 leads to tubulation of the ER (D, G and J) and a parallel alteration of microtubules (E). The microtubules appear thickened (E) and co-align with the ER (F). Bar, 10 μm. (Schweizer et al., 1993b) .
determinant of the p63 tail are spatially different. To test this notion, the Δ2-21 p63 construct was generated in which 20 amino acids close to the N-terminus were deleted. This construct thus lacks the putative ER rearrangement determinant. Expression of Δ2-21 in COS cells resulted in a morphological pattern distinct from that observed with wild-type p63 and Δ24-101. Neither the microtubule pattern nor the reticular appearance of the ER were affected ( Figure 4A and B). The ER still extended as a network throughout the entire cytoplasm, as demonstrated by the localization of p63-positive membranes relative to the nuclear membrane and to the cell border ( Figure 4D -F and G-I), and co-localized significantly with microtubules ( Figure 4A -C). Consistent with these morphological findings, construct Δ2-21 was found to bind to microtubules in vitro with an efficiency comparable with that of wildtype p63 ( Figure 2C ). These findings suggest that amino acids 2-21 comprise a determinant required for ER rearrangement that functions independently from the microtubule-binding determinant which is contained within amino acids 24-101. Moreover, the results show that bundling of the ER membranes is not a prerequisite for microtubule binding.
The isolated cytoplasmic domain of p63 binds to microtubules in vivo and in vitro
To test whether the cytoplasmic domain of p63 is sufficient for microtubule binding, a construct encompassing the cytoplasmic portion with an additional C-terminal c-myc tag (p63tail-myc) was expressed in COS cells. The subcellular localization of p63tail-myc showed a fine reticular/ tubular pattern co-localizing with microtubules ( Figure  5A -C), while no bundling of microtubules was observed. While sufficient for microtubule binding, the isolated cytoplasmic tail was unable to induce microtubule bundling, suggesting that the cytoplasmic domain needs to be anchored to the ER to promote microtubule bundling.
Unlike wild-type p63, its isolated cytoplasmic domain did not rearrange the ER. Obviously such a change requires the additional presence of other p63 domains.
To confirm further that the cytoplasmic determinant required for ER-microtubule interactions carries microtubule-binding information, a His 6 -tagged peptide corresponding to amino acids 1-106 was produced in Escherichia coli, purified by Ni-agarose affinity chromatography, and its binding to microtubules was tested in vitro. Figure 6 shows that this fragment can indeed bind to microtubules while a control peptide (a His 6 -tagged peptide corresponding to amino acids 39-189 of the leptin receptor) was unable to bind. Together with the in vitro binding experiments in which purified intact p63 was tested (Figure 2A ), these data strongly suggest that the cytoplasmic domain can bind directly to microtubules in vitro. Obviously amino acids 1-106 in p63 comprise microtubule-binding information which is independent of the rest of the molecule.
To test whether the cytoplasmic domain of p63 can induce tubulin polymerization in vitro, we used a turbidity assay in which the absorbance at 350 nm was measured. The incubation of a tubulin preparation with the recombinant peptide corresponding to the cytoplasmic domain of p63 led to a concentration-dependent increase in absorbance over time, with a threshold at 10 μM peptide (Figure 7c-g ). The increase in absorbance was preceded by a lag phase of~1 min at peptide concentrations ജ10 μM. A 20 μM peptide concentration induced the same maximal turbidity as 20 μM taxol ( Figure 7h ) though with slower kinetics. Incubation of tubulin with buffer alone (Figure 7a ) or 20 μM bovine serum albumin (BSA) (Figure 7b ) did not increase the absorbance, and the p63 peptide-induced turbidity change required the presence of tubulin in the assay (not shown). These data suggest that the cytoplasmic domain of p63 is able to promote tubulin polymerization in vitro.
Discussion
Numerous previous studies have suggested that the ER network is connected to microtubules. This interaction is believed to determine the structure and dynamics of the ER (Terasaki et al., 1986; Lee and Chen, 1988) . Although in vitro data have provided compelling evidence that microtubule motors play a role in tubular network formation of the ER (Dabora and Sheetz, 1988; Vale and Hotani, 1988; Allan, 1995b ), the precise mechanism by which this organelle maintains its characteristic structure in vivo is largely unknown.
Here we report a novel mode of interaction by which an integral membrane protein, p63, can link the ER and microtubules directly. That p63 binds to microtubules in vivo became apparent due to the remarkable ability of p63 to rearrange the ER upon its overexpression, which led to a concomitant redistribution of microtubules. The information for ER rearrangement is localized in the first 23 amino acids of p63, since the construct Δ24-101 could still induce this phenotype while the construct Δ2-21 was unable to do so. Obviously when overexpressed, the first 23 amino acids are necessary to cross-link the ER as indicated by the increased thickness of the tubular ER elements observed in this study and the previously reported parallel arrangement of ER membranes seen in electron micrographs (Schweizer et al., 1995) . It is conceivable that the capacity of p63 to form large aggregates in the ER (Schweizer et al., 1994) is related intimately to ER tubule formation, but the precise mechanism underlying this rearrangement remains to be determined. Overexpression of some invariant chain mutations in the ER can also lead to a tubular remodeling of the ER (Schutze et al., 1994) , but it has not been investigated whether this change involves microtubules.
Our in vivo and in vitro experiments showed that amino acids 24-101 in the cytoplasmic tail of p63 are required for linking the ER to microtubules while the first 23 amino acids conferring tubule formation were dispensable for this interaction. The interaction with microtubules appears to be a direct one, since purified p63 as well as its isolated cytoplasmic domain can bind to microtubules. We conclude, therefore, that amino acids 24-101 comprise a microtubule-binding determinant. The in vitro sedimentation assays showed a consistent~50% microtubule binding for all forms of p63 irrespective of their origin or purity, suggesting an intrinsically low affinity of this interaction.
It is important to note that the Δ2-21 construct which bound to microtubules like wild-type p63 was not mislocalized to post-ER compartments, indicating that the peptide segment comprising the microtubule-binding domain, either alone or together with the transmembrane and/or lumenal domain of p63, confers retention in the ER. This retention is not mediated by microtubules, since the construct Δ2-21 also remained in the ER when micro- tubules were depolymerized by nocodazole treatment (not shown). A previous mutagenesis study has shown that amino acids 1-23 also contain information for ER retention (Schweizer et al., 1994) . Obviously the retention information provided by the cytosolic tail of p63 is highly redundant.
The rearrangement of the ER does not depend strictly on the expression level of p63. Both at early (24 h) and late (72 h) times after transfection,~40% of the transfected COS cells exhibited a tubular appearance of the ER although p63 levels increased considerably between 24 and 72 h. Moreover, a strict correlation of tubulation and fluorescence signal was not observed when cells of the same transfected cell culture dish were compared visually. It is also important to note that the expression levels of the different p63 constructs were in the same range as compared by Western blotting (not shown), excluding the trivial possibility that the different ER phenotypes simply reflected different expression levels. That tubulation did not depend strictly on p63 expression levels may suggest that additional mechanistic factors are involved in ER rearrangement.
The region providing microtubule binding does not have any significant sequence similarities to the microtubulebinding domains of MAP2, MAP4 and tau Lewis et al., 1988; Chapin and Bulinski, 1991) or to that of MAP1B (Noble et al., 1989) . In a previous study, an in vitro interaction of the E3/19K adenovirus membrane protein and microtubules was reported and found to depend on a motif related to microtubule-binding Change in absorbance at 350 nm was measured at 37°C. In the absence of tubulin, 10 μM of the p63 peptide had no effect on the absorbance (not shown). As a positive control, tubulin polymerization in the presence of 20 μM taxol is shown in (h).
repeats present in MAP2 and tau (Dahllöf et al., 1991) . However, this in vitro finding was not validated in an in vivo system. Numerous other microtubule-binding proteins are known for which the binding domain has, at least in part, been characterized; none of these, however, appears to share similarity with the microtubule-binding domain of p63. They include Stu2p/p93 dis1 that localizes to the spindle pole body and along spindle microtubules of yeast (Nakaseko et al., 1996; Wang and Huffaker, 1997) , the plus-end motor protein kinesin (Woehlke et al., 1997) , and the minus-end motor dynein (Gee et al., 1997; Koonce, 1997) . Common to all these proteins is that their microtubule-binding domain is positively charged and their binding to microtubules is sensitive to salt (Vallee, 1986) , suggesting that they bind to microtubules through electrostatic interactions. The microtubule binding of p63 in vitro is also salt dependent, suggesting an ionic interaction, although binding was only affected by salt concentrations Ͼ200 mM NaCl (not shown). Protein binding to microtubules can also be mediated by Src homology 2 domains of signaling molecules (Itoh et al., 1996) . No Src homology 2 domain is present in the microtubulebinding domain of p63.
The recombinant cytoplasmic domain of p63 was found to exert a concentration-dependent stimulatory effect on tubulin polymerization in vitro, confirming the existence of at least one microtubule-binding domain in p63. In contrast to p63, the microtubule-binding domains of MAPs are known to contain multiple repeats of determinants that are essential for binding. However, studies with MAP2 have shown that the microtubule-related properties including tubulin polymerization in vitro can arise from a single 31-amino-acid repeat, although the precise mechanism by which this occurs is unknown (Ludin et al., 1996) . The microtubule-binding region of p63 may contain two binding sites that are capable of tethering two neighboring tubulin subunits together. Alternatively, a single binding site may modify the features of the tubulin subunit to which it binds and thereby increase its affinity for other tubulin molecules. It is possible that the expressed cytosolic domain of p63 is even capable of bundling microtubules when present in relatively high concentrations. This is indicated by the fact that the experiment with 20 μM p63tail reached an OD similar to that of 20 μM taxol. Bundled microtubules have much higher ODs than unbundled ones at similar polymer concentrations and, at this concentration of taxol, much of the OD is contributed normally by bundling. Additional experiments are required to confirm this suggestion.
In addition to motor proteins, organelle-microtubule interactions involve the activity of CLIPs (Richard and Kreis, 1996) , such as CLIP-170 that links endosomes to microtubules (Pierre et al., 1992 (Pierre et al., , 1994 and CLIP-115, a brain-specific protein that mediates the localization of dendritic lamellar bodies (De Zeeuw et al., 1997) . These two proteins share a double repeated microtubule-binding domain, which can also be found in various other proteins including the p150 Glued subunit of the dynactin complex (for a recent comparison of these microtubule-binding domains, see De Zeeuw et al., 1997) . Again no sequence similarity to p63 is apparent. Unlike p63, CLIPs are soluble proteins preferentially associated with microtubules. In order to promote docking of organelles to microtubules, CLIPs must interact with membrane receptors that are still unknown.
The microtubule-binding domain of p63 has a number of interesting features of potential importance for its binding to microtubules: strings of consecutive identical amino acids (i.e. prolines, glycines, serines, alanines) and a repeated tetrapeptide motif, HPQQ. Moreover, p63 is palmitoylated reversibly during mitosis and by inhibitors interfering with membrane traffic (Mundy and Warren, 1992; Schweizer et al., 1993; Mundy, 1995) . However, it is presently unclear which features in fact determine the binding of p63 to microtubules. Despite extensive mutagenesis of this region (unpublished), it was not possible to define a continuous minimal microtubulebinding motif. It appears that three-dimensional structural information will be required in addition to mutagenesis to define the microtubule-binding domain of p63.
It is likely that other organellar membrane proteins will be found in the endomembrane system that can bind directly to the cytoskeleton. We propose to name these proteins CLIMPs (cytoskeleton-linking membrane proteins) and accordingly rename p63 to CLIMP-63. Another potential CLIMP is the Golgi protein giantin Hauri, 1993, 1994) . CLIMP-63 may stabilize the ER in its reticular appearance by directly anchoring it to microtubules and/or stabilizing microtubules. In line with such a proposed function are the observations that the ER retracts from peripheral to more central areas of the cytoplasm upon overexpression of mutant Δ24-101 which is unable to bind microtubules, and the selective localization of CLIMP-63 in the reticular part of the rough ER. Experiments with living epithelial cells have shown that only a small proportion of cells possess actively moving ER, while in most cells the ER is less dynamic (Lee and Chen, 1988) . It was suggested that these movements may be limited to a particular phase of the cell cycle that requires ER proliferation. In conjunction with CLIPs and molecular motors, CLIMPs may also regulate the dynamic interaction of organelles with the cytoskeleton. CLIMP-63 may play a role in de novo ER network formation by anchoring tubulo-vesicular membranes to microtubules and thereby aiding motor protein-driven tubulation that ultimately will result in an ER network. Although CLIMP-63 can bind directly to microtubules in vitro, it is conceivable that additional proteins will be required for the regulation of this interaction in vivo, in particular during mitosis when the microtubules are required for spindle formation.
Materials and methods

Antibodies
The following primary antibodies were used: mouse mAb G1/296 (an IgG2a) against p63 (Schweizer et al., 1994) ; mouse mAb 1A2 (an IgG3) against α-tubulin (kindly provided by Thomas Kreis, University of Geneva; Kreis, 1987) ; mouse mAb 414 (an IgG1) against nuclear pore complex protein p62 (BAbCO, Richmond, CA, kindly provided by Birthe Fahrenkrog, Biozentrum Basel, Switzerland); and mouse mAb 9E10.2 (an IgG1) (Evan et al., 1985) against the c-myc epitope. mAbs against BAP31 (an IgG1) and ERP72 (an IgG1) were produced in mice by the hybridoma technique (Hauri et al., 1985) using a membrane fraction of Vero cells enriched in ERGIC-53 (Schweizer et al., 1991) as an antigen. Antibody specificity was established by N-terminal sequencing of the recognized antigens (Schweizer et al., 1993b) . Mouse mAb N1/123 (an IgG1) against the α-subunit of Na-K-ATPase was produced by using a membrane fraction of human kidney enriched in Na-KATPase (Jorgensen, 1974) as an antigen and the immunization protocol of Kashgarian (1985) . Secondary antibodies were: fluorescein isothiocyanate (FITC)-goat anti-mouse IgG3 (ICN, Eschwege, Germany); Texas red-goat anti-mouse IgG2a; Texas red-goat anti-mouse IgG1; and FITCgoat anti-mouse IgG1 (Southern Biotech., Birmingham, AL).
Cell culture and transfection COS cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS), 100 U/ml penicillin, 100 μg/ml streptomycin and 1 μg/ml fungizone at 37°C according to standard techniques. The cells were transiently transfected using the DEAE-dextran method (Cullen, 1987) .
Recombinant DNAs and expression of recombinant protein p63 cDNA was mutated using standard PCR protocols. Construct Δ24-101 has been described (Schweizer et al., 1993b) . Inserts were excised from the pECE vector with EcoRI and blunt-end ligated into the EcoRV site of a modified pcDNA3 vector (Invitrogen, Leer, The Netherlands) lacking the NotI restriction site to give the plasmids pcDNA3-p63 or pcDNA3-Δ24-101. For the construction of the Δ2-21 mutant, pcDNA3-p63 was used as template for PCR. For the construction of p63tail-myc, the DNA sequence coding for the c-myc epitope EQKLISEEDL followed by the translation termination codon TAA was introduced after amino acid position 106 of p63 by PCR. A His 6 -tagged construct encompassing amino acids 1-106 of the cytoplasmic domain of p63 was obtained by PCR amplification of the corresponding DNA sequence using an upstream primer with an SphI and a downstream primer with a BglII restriction site. The resulting fragment was cloned into the SphI-BglII site of the E.coli expression vector pQE-70 (Qiagen, Basel, Switzerland). The recombinant His 6 -tagged peptide was expressed in E.coli strain M15 and purified by Ni-agarose affinity chromatography.
Affinity purification of p63
After 60 h of transfection with wild-type p63 cDNA, COS cells were harvested by scraping followed by centrifugation for 10 min at 750 g at 4°C. Cell pellets were solubilized for 1 h on ice in 100 mM NaH 2 PO 4 pH 8.0, containing 1% Triton X-100 and protease inhibitors, and subsequently centrifuged for 1 h at 100 000 g. p63 protein was affinity purified from the resulting supernatant on a column of mAb G1/296 coupled to Affi gel-10. The protein was eluted with 0.05 M triethylamine pH 11.5, 0.1% Triton X-100, and the eluates were adjusted immediately to pH 7.0 with 1 M Tris base. Fractions containing the purified p63 were pooled and dialyzed against PNT buffer (20 mM PIPES, 30 mM Tris, 100 mM NaCl, 1 mM EGTA, 1.25 mM EDTA), pH 7.0, containing 0.1% Triton X-100 and 40 μg/ml phenylmethylsulfonyl fluoride (PMSF).
Confocal laser scanning immunofluorescence microscopy
Transiently transfected COS cells were trypsinized 24 h after transfection and seeded into 8-well multi-chamber slides. After 19-20 h, the cells were fixed with paraformaldehyde, permeabilized with 0.1% saponin, and processed for immunofluorescence microscopy (Schweizer et al., 1993a) . The specimens were examined with a Leica confocal laser scanning microscope (0.28 μm optical sections). Corrections of bleedthrough in double-labeling experiments were done according to the recommendations of the manufacturer and were tested in single-labeling experiments.
Microtubule binding assay
Tubulin was prepared from pig brain by two temperature-induced cycles of microtubule assembly by the method of Weingarten et al. (1974) with slight modifications. The brain was homogenized in 1 ml of assembly buffer per gram of brain tissue [0.1 M N-morpholinoethanesulfonic acid (MES), 1 mM EGTA, 1 mM MgSO 4 , 40 μg/ml PMSF, pH 6.8] containing 0.5 M sucrose. Homogenization was performed with a Teflon/glass homogenizer at 4°C. The homogenate was centrifuged at 54 000 g for diluted 1:1 with assembly buffer containing 7 M glycerol, warmed to 37°C for 45 min, centrifuged at 100 000 g for 60 min at 26°C, and the supernatant was discarded. The pellet was resuspended in 0.3 ml of assembly buffer per gram of brain, incubated on ice for 30 min and centrifuged at 69 000 g for 20 min at 4°C. The supernatants were diluted 1:1 with assembly buffer containing 7 M glycerol, warmed at 37°C for 45 min and centrifuged for 60 min at 100 000 g at 26°C. The pellets containing the purified microtubules were resuspended in assembly buffer, frozen in liquid nitrogen and stored at -80°C.
After 52-62 h of transfection, COS cells of a 60 mm dish were washed twice with ice-cold phosphate-buffered saline (PBS), scraped into 1 ml of PBS and collected by centrifugation for 10 min at 750 g at 4°C. The cells were solubilized in 1 ml of PNT buffer, pH 7.0, containing 1% Triton X-100, 100 mM iodoacetamide and protease inhibitors. Tubulin (5 mg/ml in buffer A: 100 mM MES, 1 mM EGTA, 1 mM MgCl 2 , pH 6.8) was polymerized with 30 μM taxol in the presence of 2.5 mM GTP, 350 mM NaCl for 30 min at 37°C. For microtubule binding, 30 μg of repolymerized microtubules per assay were pelleted by centrifugation for 30 min at 20 800 g in an Eppendorf centrifuge. The microtubules were washed once with buffer A, resuspended in 80 μl of solubilized cell supernatant (or purified p63) containing 20 μM taxol and incubated for 30 min at 37°C. The sample was then centrifuged at 20 800 g, and supernatant and pellet were analyzed by SDS-PAGE and Western blotting for the presence of tubulin and p63.
In vitro polymerization
The polymerization of pig brain tubulin was monitored at 350 nm in a Uvikon 820 spectrophotometer. Tubulin at a concentration of 1 mg/ml in assembly buffer containing 1 mM GTP was mixed with various amounts of the recombinant cytoplasmic domain of p63 to a final volume of 400 μl and the increase of absorbance at 350 nm was measured at 37°C.
